What is the clinical significance of an absent A‑wave in the ductus venosus (DV) of an intra‑uterine growth‑restricted (IUGR) fetus?

Clinical Significance of Absent A-Wave in Ductus Venosus in Growth-Restricted Fetuses

An absent A-wave in the ductus venosus of a growth-restricted fetus represents advanced fetal cardiac compromise with dramatically elevated risk of stillbirth (20% overall, 46% if reversed A-wave), requiring immediate intensification of surveillance and strong consideration for delivery based on gestational age. 1

Pathophysiology and Prognostic Implications

The absent or reversed A-wave in the ductus venosus reflects increased central venous pressure from elevated right ventricular end-diastolic pressure and decreased cardiac muscle compliance—this is a late-stage manifestation of fetal decompensation 1. The odds ratio for stillbirth with absent or reversed A-wave is 11.16 (95% CI, 6.31-19.73) in FGR fetuses <34 weeks 1.

Recent data confirms this finding is associated with:

• 100% rate of acidosis (pH <7.20) 2
• 75% with Apgar 0-3 at 1 minute, 25% at 5 minutes 2
• 100% neonatal morbidity 2
• Universal neurological injury in the first month of life 2

Critical Timing Consideration

The duration of abnormal ductus venosus flow matters significantly. Persistent absent/reversed A-wave for >7 days predicts stillbirth with 100% sensitivity and 80% specificity 3. This duration is the only independent predictor of stillbirth when present, superseding even gestational age 3.

Clinical Management Algorithm

When Absent A-Wave is Detected:

1. Immediate Actions:

   • Hospitalize the patient 1
   • Administer antenatal corticosteroids if <34 weeks 1
   • Initiate cardiotocography at least 1-2 times daily 1
   • Prepare for delivery based on gestational age

2. Delivery Timing Based on Umbilical Artery Doppler:

   • Absent end-diastolic velocity in umbilical artery: deliver at 33-34 weeks 1
   • Reversed end-diastolic velocity in umbilical artery: deliver at 30-32 weeks 1
   • Consider cesarean delivery based on the entire clinical scenario 1

3. Magnesium Sulfate:

   • Administer for neuroprotection if <32 weeks 1

Important Caveats and Context

Guideline Limitations

Despite the clear prognostic significance, SMFM guidelines (2020) suggest NOT using ductus venosus Doppler for routine clinical management (GRADE 2B) 1. This recommendation reflects:

• Absent/reversed A-wave occurs in only 41% of fetuses even with absent/reversed umbilical artery end-diastolic velocity 1
• After 32 weeks, abnormal cardiotocography almost invariably precedes ductus venosus abnormalities 1
• The TRUFFLE trial showed benefit, but delivery decisions based on ductus venosus findings occurred in only 11% of cases 1

When to Suspect Alternative Pathology

Critical distinction: If ductus venosus shows absent/reversed A-wave but umbilical artery Doppler is normal, this suggests alternative pathophysiology—likely fetal cardiac, vascular, or genetic abnormalities rather than placental disease 1. In this scenario, pursue:

• Detailed fetal echocardiography
• Genetic testing with chromosomal microarray 1
• Assessment for structural anomalies

Practical Application

While guidelines don't recommend routine ductus venosus surveillance, when it is performed and shows absent/reversed A-wave in the context of FGR with abnormal umbilical artery Doppler, this finding should trigger immediate action as outlined above. The evidence clearly demonstrates this represents imminent risk of fetal demise that cannot be ignored, even if not part of routine surveillance protocols.

The key is recognizing that umbilical artery Doppler remains the primary surveillance tool 1, 4, but when ductus venosus abnormalities are identified, they carry independent and severe prognostic weight requiring urgent intervention.